Foghorn Therapeutics Inc. (FHTX)
Nasdaq: FHTX · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Mar 11, 2026 | Mar 6, 2025 | Mar 7, 2024 | Mar 9, 2023 | Mar 10, 2022 | Mar 18, 2021 | · |
| Revenue | 30,909 | 22,602 | 34,155 | 19,228 | 1,319 | 430 | · |
| Research and development | 85,466 | 94,528 | 109,689 | 105,618 | 80,325 | 57,715 | 44,362 |
| General and administrative | 27,550 | 28,359 | 32,372 | 30,747 | 21,728 | 11,246 | 6,722 |
| Total operating expenses | 117,298 | 125,285 | 142,061 | 136,365 | 102,053 | 68,961 | 51,084 |
| Operating income | -86,389 | -102,683 | -107,906 | -117,137 | -100,734 | -68,531 | -51,084 |
| Interest expense | · | · | · | · | 1,906 | 979 | 540 |
| Interest and investment income | 8,745 | 11,900 | 10,875 | 5,675 | 59 | · | · |
| Other income (expense), net | · | · | · | 2,580 | 2,494 | · | · |
| Total non-operating income (expense) | 12,106 | 16,063 | 13,706 | 8,255 | -586 | -269 | -44 |
| Income before income taxes | · | -86,620 | -94,200 | -108,882 | · | · | · |
| Income tax expense | 0 | 0 | 4,226 | 0 | · | 0 | 0 |
| Net income including non-controlling interests | · | · | · | · | · | -68,800 | -51,128 |
| Net income | -74,283 | -86,620 | -98,426 | -108,882 | -101,320 | -68,800 | -51,128 |
| Earnings per share, basic | -1.18 | -1.58 | -2.34 | -2.62 | -2.73 | -6.23 | · |
| Earnings per share, diluted | -1.18 | -1.58 | -2.34 | -2.62 | -2.73 | -6.23 | · |
| Earnings per share, basic and diluted | · | · | · | · | · | -6.23 | -12.20 |
| Weighted average shares, basic | 62,980,959 | 54,899,432 | 41,974,484 | 41,591,433 | 37,171,147 | 11,046,802 | · |
| Weighted average shares, diluted | 62,980,959 | 54,899,432 | 41,974,484 | 41,591,433 | 37,171,147 | 11,046,802 | · |
| Weighted average shares, basic and diluted | · | · | · | · | · | 11,046,802 | 4,191,793 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InterestIncomeOtherOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted